CHM chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-60

  1. 4,663 Posts.
    lightbulb Created with Sketch. 2153
    I think we may see things in the same light.

    However, for some who are seeing a lot of red in their portfolio, it becomes a stressful time.

    I understand why investors become disheartened and sell out. But it's sad when this happens at this market cap with this pipeline.

    It's a lot easier when your average price is 1.8c instead of 30c, which i think a few holders will still be at.

    The pipeline is still progressing. There is now no value given to the science (pipeline) in the market cap. This is a huge opportunity for some.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $10.07M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $11.08K 2.623M

Buyers (Bids)

No. Vol. Price($)
8 4706271 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14960701 24
View Market Depth
Last trade - 11.14am 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.